These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30503632)

  • 1. The discovery of VU0652957 (VU2957, Valiglurax): SAR and DMPK challenges en route to an mGlu
    Panarese JD; Engers DW; Wu YJ; Guernon JM; Chun A; Gregro AR; Bender AM; Capstick RA; Wieting JM; Bronson JJ; Macor JE; Westphal R; Soars M; Engers JE; Felts AS; Rodriguez AL; Emmitte KA; Jones CK; Blobaum AL; Conn PJ; Niswender CM; Hopkins CR; Lindsley CW
    Bioorg Med Chem Lett; 2019 Jan; 29(2):342-346. PubMed ID: 30503632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of VU2957 (Valiglurax): An mGlu
    Panarese JD; Engers DW; Wu YJ; Bronson JJ; Macor JE; Chun A; Rodriguez AL; Felts AS; Engers JL; Loch MT; Emmitte KA; Castelhano AL; Kates MJ; Nader MA; Jones CK; Blobaum AL; Conn PJ; Niswender CM; Hopkins CR; Lindsley CW
    ACS Med Chem Lett; 2019 Mar; 10(3):255-260. PubMed ID: 30891122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 3-aminopicolinamides as metabotropic glutamate receptor subtype 4 (mGlu4) positive allosteric modulator warheads engendering CNS exposure and in vivo efficacy.
    Gogliotti RD; Engers DW; Garcia-Barrantes PM; Panarese JD; Gentry PR; Blobaum AL; Morrison RD; Daniels JS; Thompson AD; Jones CK; Conn PJ; Niswender CM; Lindsley CW; Hopkins CR
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2915-2919. PubMed ID: 27131990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and optimization of a novel CNS penetrant series of mGlu
    Kent CN; Fulton MG; Stillwell KJ; Dickerson JW; Loch MT; Rodriguez AL; Blobaum AL; Boutaud O; Rook JL; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2021 Apr; 37():127838. PubMed ID: 33556572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 3. Engineering plasma stability by discovery and optimization of isoindolinone analogs.
    Garcia-Barrantes PM; Cho HP; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1869-72. PubMed ID: 26988302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead optimization of the VU0486321 series of mGlu(1) PAMs. Part 2: SAR of alternative 3-methyl heterocycles and progress towards an in vivo tool.
    Garcia-Barrantes PM; Cho HP; Metts AM; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2016 Feb; 26(3):751-756. PubMed ID: 26778256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The discovery of VU0486846: steep SAR from a series of M
    Bertron JL; Cho HP; Garcia-Barrantes PM; Panarese JD; Salovich JM; Nance KD; Engers DW; Rook JM; Blobaum AL; Niswender CM; Stauffer SR; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2018 Jul; 28(12):2175-2179. PubMed ID: 29754948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5).
    Martín-Martín ML; Bartolomé-Nebreda JM; Conde-Ceide S; Alonso de Diego SA; López S; Martínez-Viturro CM; Tong HM; Lavreysen H; Macdonald GJ; Steckler T; Mackie C; Bridges TM; Daniels JS; Niswender CM; Noetzel MJ; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1310-7. PubMed ID: 25683622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re-exploration of the mGlu₁ PAM Ro 07-11401 scaffold: Discovery of analogs with improved CNS penetration despite steep SAR.
    Garcia-Barrantes PM; Cho HP; Starr TM; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW
    Bioorg Med Chem Lett; 2016 May; 26(9):2289-92. PubMed ID: 27013388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of dihydropyrazino-benzimidazole derivatives as metabotropic glutamate receptor-2 (mGluR2) positive allosteric modulators (PAMs).
    Szabó G; Kolok S; Orgován Z; Vastag M; Béni Z; Kóti J; Sághy K; Lévay GI; Greiner I; Keserű GM
    Eur J Med Chem; 2020 Jan; 186():111881. PubMed ID: 31780081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers.
    Niswender CM; Jones CK; Lin X; Bubser M; Thompson Gray A; Blobaum AL; Engers DW; Rodriguez AL; Loch MT; Daniels JS; Lindsley CW; Hopkins CR; Javitch JA; Conn PJ
    ACS Chem Neurosci; 2016 Sep; 7(9):1201-11. PubMed ID: 27441572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and SAR of a novel series of non-MPEP site mGlu₅ PAMs based on an aryl glycine sulfonamide scaffold.
    Rodriguez AL; Zhou Y; Williams R; Weaver CD; Vinson PN; Dawson ES; Steckler T; Lavreysen H; Mackie C; Bartolomé JM; Macdonald GJ; Daniels JS; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7388-92. PubMed ID: 23142615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lead optimization of the VU0486321 series of mGlu
    Davis DC; Bungard JD; Chang S; Rodriguez AL; Blobaum AL; Boutaud O; Melancon BJ; Niswender CM; Jeffrey Conn P; Lindsley CW
    Bioorg Med Chem Lett; 2021 Jan; 32():127724. PubMed ID: 33253881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and SAR of a series of mGlu
    Kalbfleisch JJ; Reed CW; Park C; Spearing PK; Quitalig MC; Jenkins MT; Rodriguez AL; Blobaum AL; Conn PJ; Niswender CM; Lindsley CW
    Bioorg Med Chem Lett; 2020 Nov; 30(22):127529. PubMed ID: 32890686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of dual positive allosteric modulators (PAMs) of the metabotropic glutamate 2 receptor and CysLT1 antagonists for treating migraine headache.
    Blanco MJ; Benesh DR; Knobelsdorf JA; Khilevich A; Cortez GS; Mokube F; Aicher TD; Groendyke TM; Marmsater FP; Tang TP; Johnson KW; Clemens-Smith A; Muhlhauser MA; Swanson S; Catlow J; Emkey R; Johnson MP; Schkeryantz JM
    Bioorg Med Chem Lett; 2017 Jan; 27(2):323-328. PubMed ID: 27908761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery, Synthesis, and Preclinical Characterization of N-(3-Chloro-4-fluorophenyl)-1H-pyrazolo[4,3-b]pyridin-3-amine (VU0418506), a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu4).
    Engers DW; Blobaum AL; Gogliotti RD; Cheung YY; Salovich JM; Garcia-Barrantes PM; Daniels JS; Morrison R; Jones CK; Soars MG; Zhuo X; Hurley J; Macor JE; Bronson JJ; Conn PJ; Lindsley CW; Niswender CM; Hopkins CR
    ACS Chem Neurosci; 2016 Sep; 7(9):1192-200. PubMed ID: 27075300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further optimization of the mGlu5 PAM clinical candidate VU0409551/JNJ-46778212: Progress and challenges towards a back-up compound.
    Zhou Y; Malosh C; Conde-Ceide S; Martínez-Viturro CM; Alcázar J; Lavreysen H; Mackie C; Bridges TM; Daniels JS; Niswender CM; Jones CK; Macdonald GJ; Steckler T; Conn PJ; Stauffer SR; Bartolomé-Nebreda JM; Lindsley CW
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3515-9. PubMed ID: 26183084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the development of an M
    Wood MR; Noetzel MJ; Poslusney MS; Melancon BJ; Tarr JC; Lamsal A; Chang S; Luscombe VB; Weiner RL; Cho HP; Bubser M; Jones CK; Niswender CM; Wood MW; Engers DW; Brandon NJ; Duggan ME; Conn PJ; Bridges TM; Lindsley CW
    Bioorg Med Chem Lett; 2017 Jan; 27(2):171-175. PubMed ID: 27939174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opportunities and challenges in drug discovery targeting metabotropic glutamate receptor 4.
    Volpi C; Fallarino F; Mondanelli G; Macchiarulo A; Grohmann U
    Expert Opin Drug Discov; 2018 May; 13(5):411-423. PubMed ID: 29486616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and SAR of a novel metabotropic glutamate receptor 4 (mGlu4) antagonist: unexpected 'molecular switch' from a closely related mGlu4 positive allosteric modulator.
    Utley T; Haddenham D; Salovich JM; Zamorano R; Vinson PN; Lindsley CW; Hopkins CR; Niswender CM
    Bioorg Med Chem Lett; 2011 Dec; 21(23):6955-9. PubMed ID: 22030026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.